Nature Medicine
5, 621 - 622 (1999)
doi:10.1038/9465
COX-2 Inhibitors − Is there cause for concern?Karen Seibert, James Lefkowith, Catherine Tripp, Peter Isakson
& Philip Needleman
Searle Research and Development 4901
Searle Parkway Skokie, Illinois 60077,
USA
A new study calls for further investigation into the potential benefits
and risks of COX-2 specific inhibitors (pages 698−701).
|
